Literature DB >> 8931632

Protein oxidation in hemodialysis and kidney transplantation.

P Odetti1, S Garibaldi, G Gurreri, I Aragno, D Dapino, M A Pronzato, U M Marinari.   

Abstract

Oxidative damage of plasma proteins determined with the markers carbonyl group (CG) content and thiobarbituric acid-reactive substances (TBARS) was studied in 13 hemodialyzed and eight kidney-transplanted patients. The level of CGs was 38% higher in hemodialysis (HD) patients (1.49 +/- 0.05 nmol/mg protein) than in the healthy subjects (1.08 +/- 0.03 nmol/mg protein); the TBARS level was also higher in HD patients than in the control group (2.64 +/- 0.15 v 1.81 +/- 0.09 nmol/mL, P < .001). These data confirm that in end-stage renal failure, an increased oxidative stress is present and is able to induce protein damage. After transplantation, the CG content in protein was reduced (1.34 +/- 0.08 nmol/mg protein), but it was not significantly different from the level in the HD group. The failure to return to the normal range suggests that an impaired redox status is maintained, resulting in a sustained elevation of CG. Conversely, the level of TBARS in transplanted patients (1.99 +/- 0.22 nmol/mL) was not significantly different from that in the control group (1.81 +/- 0.09), suggesting that lipoperoxidation may be inhibited. These results may be explained by the different turnover rates of the molecules and by the distinct origin of the two markers, resulting from the damage of proteins or lipids. Thus, lipoperoxidation would produce rapidly removable molecules, whereas protein oxidation damage would tend to accumulate. However, the significant correlation found between CGs and TBARS indicates that a common cause (oxidative stress) binds the two markers of damage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931632     DOI: 10.1016/s0026-0495(96)90108-0

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  7 in total

1.  Lipid peroxidation and growth inhibition of human microvascular endothelial cells.

Authors:  A T Høstmark; E Lystad
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-10       Impact factor: 2.416

Review 2.  Pathways of the Maillard reaction under physiological conditions.

Authors:  Christian Henning; Marcus A Glomb
Journal:  Glycoconj J       Date:  2016-06-13       Impact factor: 2.916

3.  Evaluation of oxidative stress markers for the early diagnosis of allograft rejection in feline renal allotransplant recipients with normal renal function.

Authors:  Krista B Halling; Gary W Ellison; Don Armstrong; Kasumi Aoyagi; Carol J Detrisac; John P Graham; Susan P Newell; Frank G Martin; James M Van Gilder
Journal:  Can Vet J       Date:  2004-10       Impact factor: 1.008

4.  Paraoxonase activity and antibodies to oxidized-LDL in chronic renal failure patients on renal replacement therapy.

Authors:  P R Krishnaswamy; Anjali Rao; W Murali; H Sudarshan Ballal
Journal:  Indian J Clin Biochem       Date:  2006-09

5.  Direct measurement of reactive oxygen species in leukocytes during hemodialysis therapy.

Authors:  Kazuhiro Okano; Kazuo Kimura; Yoichiro Tanaka; Ken Tsuchiya; Takashi Akiba; Kosaku Nitta
Journal:  Int J Clin Exp Med       Date:  2015-11-15

6.  Effects of carnitine on oxidative stress response to intravenous iron administration to patients with CKD: impact of haptoglobin phenotype.

Authors:  Zaher Armaly; Amir Abd El Qader; Adel Jabbour; Kamal Hassan; Rawi Ramadan; Abdalla Bowirrat; Bishara Bisharat
Journal:  BMC Nephrol       Date:  2015-08-13       Impact factor: 2.388

Review 7.  Mitochondria: a new therapeutic target in chronic kidney disease.

Authors:  Simona Granata; Alessandra Dalla Gassa; Paola Tomei; Antonio Lupo; Gianluigi Zaza
Journal:  Nutr Metab (Lond)       Date:  2015-11-25       Impact factor: 4.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.